1044209-33-7 Usage
Uses
Used in Pharmaceutical Research:
5-BROMO-2-(DIETHOXYMETHYL)PYRIDINE is used as a reagent in pharmaceutical research for its potential applications in the development of new drugs. Its antimicrobial and antifungal properties make it a promising candidate for creating treatments against various infections.
Used in Organic Synthesis:
In the field of organic synthesis, 5-BROMO-2-(DIETHOXYMETHYL)PYRIDINE serves as an intermediate in the synthesis of various pharmaceutical and agrochemical compounds. Its unique structure allows for the creation of a wide range of molecules with different properties and applications.
Used in Agriculture:
5-BROMO-2-(DIETHOXYMETHYL)PYRIDINE is used as an intermediate in the synthesis of agrochemical compounds, contributing to the development of new pesticides and other agricultural products. Its antimicrobial and antifungal properties can be harnessed to protect crops and enhance agricultural productivity.
Used in Materials Science:
Although not explicitly mentioned in the provided materials, the versatility of 5-BROMO-2-(DIETHOXYMETHYL)PYRIDINE suggests potential applications in materials science. Its unique chemical structure could be utilized in the development of new materials with specific properties, such as conductivity, stability, or reactivity, depending on the desired application.
Check Digit Verification of cas no
The CAS Registry Mumber 1044209-33-7 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,4,4,2,0 and 9 respectively; the second part has 2 digits, 3 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1044209-33:
(9*1)+(8*0)+(7*4)+(6*4)+(5*2)+(4*0)+(3*9)+(2*3)+(1*3)=107
107 % 10 = 7
So 1044209-33-7 is a valid CAS Registry Number.
1044209-33-7Relevant academic research and scientific papers
Theramutein modulators
-
Page/Page column 174, (2010/02/17)
This invention relates to agents that are inhibitors or activators of variant forms of endogenous proteins and novel methods of identifying such variants. Of particular interest are inhibitors and activators of endogenous protein variants, encoded by genes which have mutated, which variants often arise or are at least first identified as having arisen following exposure to a chemical agent which is known to be an inhibitor or activator of the corresponding unmutated endogenous protein.
THERAMUTEIN MODULATORS
-
Page/Page column 236-237, (2008/12/07)
This invention relates to agents that are inhibitors or activators of variant forms of endogenous proteins and novel methods of identifying such variants. Of particular interest are inhibitors and activators of endogenous protein variants, encoded by genes which have mutated, which variants often arise or are at least first identified as having arisen following exposure to a chemical agent which is known to be an inhibitor or activator of the corresponding unmutated endogenous protein.
